Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -912.25% is 133% below its 3-year average of -391.24%, near the low end of its 3-year range (-1064.75%–0.00%).
0.55% above its 12-month average of -917.28%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1064.75%.
NET PROFIT MARGIN
-912.25%
NET PROFIT MARGIN AVG TTM
-917.28%
NET PROFIT MARGIN AVG 3Y
-421.34%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.55%
CURRENT VS 3Y AVG
-116.51%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 512 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
BioAge Labs Inc.
Market Cap
$241.18M
Net Profit Margin
-912.25%
TTM Avg
-917.28%
3Y Avg
-421.34%
5Y Avg
N/A
Market Cap
$239.39M
Net Profit Margin
-13.54%
TTM Avg
-22.79%
3Y Avg
-26.12%
5Y Avg
-61.39%
Market Cap
$240.32M
Net Profit Margin
-4.52%
TTM Avg
-4.68%
3Y Avg
-9.38%
5Y Avg
-10.81%
Market Cap
$244.41M
Net Profit Margin
N/A
TTM Avg
-26.91%
3Y Avg
-35.21%
5Y Avg
-46.29%
Market Cap
$240.55M
Net Profit Margin
-26.97%
TTM Avg
-50.02%
3Y Avg
-94.39%
5Y Avg
-87.59%
Market Cap
$240.38M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$247.60M
Net Profit Margin
-155582.08%
TTM Avg
-91683.52%
3Y Avg
-62749.43%
5Y Avg
-41832.95%
Market Cap
$249.24M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$247.47M
Net Profit Margin
-183.90%
TTM Avg
-383.83%
3Y Avg
-191.92%
5Y Avg
-127.94%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioAge Labs Inc. (BIOA) | $241.18M | -912.25% | -917.28% | -421.34% | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $239.39M | -13.54% | -22.79% | -26.12% | -61.39% |
| High Tide Inc. (HITI)vs › | $240.32M | -4.52% | -4.68% | -9.38% | -10.81% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $244.41M | N/A | -26.91% | -35.21% | -46.29% |
| Biodesix, Inc. (BDSX)vs › | $240.55M | -26.97% | -50.02% | -94.39% | -87.59% |
| Galectin Therapeutics Inc. (GALT)vs › | $240.38M | 0.00% | 0.00% | 0.00% | 0.00% |
| InflaRx N.V. (IFRX)vs › | $247.60M | -155582.08% | -91683.52% | -62749.43% | -41832.95% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $249.24M | 0.00% | 0.00% | 0.00% | 0.00% |
| Invivyd, Inc. (IVVD)vs › | $247.47M | -183.90% | -383.83% | -191.92% | -127.94% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $251.01M | -2543.74% | -5120.97% | -6084.02% | -4060.63% |
Operating Margin
-1026.3%
Net Profit Margin
-912.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1064.75% |
| 2026-03-31 | -802.78% |
| 2025-12-31 | -842.85% |
| 2025-09-30 | -982.04% |
| 2025-06-30 | -893.99% |
| 2025-03-31 | -890.97% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
